A NOVEL IL33 FORM, MUTATED FORMS OF IL33, ANTIBODIES, ASSAYS AND METHODS OF USING THE SAME

The present invention provides isolated IL-33 proteins, active fragments thereof and antibodies, antigen binding fragments thereof, against IL-33 proteins. Also provided are methods of modulating cytokine activity, e.g., for the purpose of treating immune and inflammatory disorders. . . La présente...

Full description

Saved in:
Bibliographic Details
Main Authors STRAIN, MARTIN D, CARMEN, SARA, OVERED-SAYER, CATHERINE L, SCOTT, IAN C, MUSTELIN, TOMAS M, KEMP, BENJAMIN P, REES, DAVID G, LOWE, DAVID C, VOUSDEN, KATHERINE A, HOUSLAY, KIRSTY, COHEN, EMMA S, ENGLAND, ELIZABETH H, SLEEMAN, MATTHEW, BUTLER, ROBIN
Format Patent
LanguageEnglish
French
Published 24.10.2023
Subjects
AGRICULTURE
ANIMAL HUSBANDRY
CARE OF BIRDS, FISHES, INSECTS
CHEMISTRY
FISHING
FORESTRY
HUMAN NECESSITIES
HUNTING
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
NEW BREEDS OF ANIMALS
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR
TRAPPING
Online AccessGet full text

Cover

More Information
Summary:The present invention provides isolated IL-33 proteins, active fragments thereof and antibodies, antigen binding fragments thereof, against IL-33 proteins. Also provided are methods of modulating cytokine activity, e.g., for the purpose of treating immune and inflammatory disorders. . . La présente invention concerne des protéines IL-33 isolées, des fragments actifs de celles-ci, ainsi que des anticorps et des fragments liant l'antigène de ceux-ci contre les protéines IL-33. L'invention concerne également des procédés de modulation de l'activité de la cytokine, par exemple pour le traitement de troubles immunitaires et inflammatoires.
Bibliography:Application Number: CA20162982400